[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI924247A - En doseringsform foer frigoerande av medicin till tarmen - Google Patents

En doseringsform foer frigoerande av medicin till tarmen Download PDF

Info

Publication number
FI924247A
FI924247A FI924247A FI924247A FI924247A FI 924247 A FI924247 A FI 924247A FI 924247 A FI924247 A FI 924247A FI 924247 A FI924247 A FI 924247A FI 924247 A FI924247 A FI 924247A
Authority
FI
Finland
Prior art keywords
tarmen
endose
till
medicine
medical
Prior art date
Application number
FI924247A
Other languages
English (en)
Other versions
FI924247A0 (fi
Inventor
Jeremy C Wright
George V Guittard
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of FI924247A0 publication Critical patent/FI924247A0/fi
Publication of FI924247A publication Critical patent/FI924247A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Surgical Instruments (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI924247A 1990-03-23 1992-09-22 En doseringsform foer frigoerande av medicin till tarmen FI924247A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/498,121 US5178866A (en) 1990-03-23 1990-03-23 Dosage form for delivering drug to the intestine
PCT/US1991/001850 WO1991014426A1 (en) 1990-03-23 1991-03-20 Dosage form for delivering drug to the intestine

Publications (2)

Publication Number Publication Date
FI924247A0 FI924247A0 (fi) 1992-09-22
FI924247A true FI924247A (fi) 1992-09-22

Family

ID=23979678

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924247A FI924247A (fi) 1990-03-23 1992-09-22 En doseringsform foer frigoerande av medicin till tarmen

Country Status (18)

Country Link
US (2) US5178866A (fi)
EP (1) EP0521074B1 (fi)
JP (1) JP2963766B2 (fi)
KR (1) KR0169145B1 (fi)
AT (1) ATE102029T1 (fi)
AU (1) AU644645B2 (fi)
CA (1) CA2038672C (fi)
DE (1) DE69101314T2 (fi)
DK (1) DK0521074T3 (fi)
ES (1) ES2062779T3 (fi)
FI (1) FI924247A (fi)
IE (1) IE62393B1 (fi)
MX (1) MX173300B (fi)
NO (1) NO923590L (fi)
NZ (1) NZ237516A (fi)
PT (1) PT97086B (fi)
WO (1) WO1991014426A1 (fi)
ZA (1) ZA912069B (fi)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5681585A (en) * 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5223265A (en) * 1992-01-10 1993-06-29 Alza Corporation Osmotic device with delayed activation of drug delivery
US7070806B2 (en) * 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5248310A (en) * 1992-03-27 1993-09-28 Alza Corporation Oral osmotic device with hydrogel driving member
US5512299A (en) * 1992-03-30 1996-04-30 Alza Corporation Method of treating oral inflammatory disease
PL175026B1 (pl) * 1992-09-18 1998-10-30 Yamanouchi Pharma Co Ltd Preparat typu hydrożelu o przedłużonym działaniu
US5358502A (en) * 1993-02-25 1994-10-25 Pfizer Inc PH-triggered osmotic bursting delivery devices
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
US5514663A (en) * 1993-10-19 1996-05-07 The Procter & Gamble Company Senna dosage form
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5849327A (en) * 1994-07-29 1998-12-15 Advanced Polymer Systems, Inc. Delivery of drugs to the lower gastrointestinal tract
FR2723536A1 (fr) * 1994-08-11 1996-02-16 Seth Pawan Composition permettant une liberation selective d'un principe actif
GB2292079B (en) * 1994-08-12 1998-07-15 Flexpharm Ltd Coated prednisolone preparation for the treatment of inflamatory bowel disease
US5736159A (en) * 1995-04-28 1998-04-07 Andrx Pharmaceuticals, Inc. Controlled release formulation for water insoluble drugs in which a passageway is formed in situ
US6361796B1 (en) 1996-10-25 2002-03-26 Shire Laboratories, Inc. Soluble form osmotic dose delivery system
AU721653B2 (en) * 1996-10-25 2000-07-13 Supernus Pharmaceuticals, Inc. Soluble form osmotic dose delivery system
US6919373B1 (en) * 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
WO1999001111A1 (en) 1997-07-02 1999-01-14 Euro-Celtique, S.A. Stabilized sustained release tramadol formulations
DE19732903A1 (de) * 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US6099862A (en) 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
IL143604A0 (en) 1998-12-30 2002-04-21 Dexcel Ltd Dispersable concentrate for the delivery of cyclosporin
US20040121014A1 (en) * 1999-03-22 2004-06-24 Control Delivery Systems, Inc. Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US6217895B1 (en) 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US6562375B1 (en) * 1999-08-04 2003-05-13 Yamanouchi Pharmaceuticals, Co., Ltd. Stable pharmaceutical composition for oral use
WO2001047498A2 (en) 1999-12-23 2001-07-05 Pfizer Products Inc. Hydrogel-driven layered drug dosage form comprising sertraline
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
AR026148A1 (es) * 2000-01-21 2003-01-29 Osmotica Argentina S A Dispositivo osmotico con pasaje preformado que aumenta de tamano
US6669954B2 (en) 2000-01-25 2003-12-30 John R. Crison Controlled release of drugs
US6375972B1 (en) * 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
US6866866B1 (en) * 2000-11-03 2005-03-15 Andrx Labs, Llc Controlled release metformin compositions
US6790459B1 (en) 2000-11-03 2004-09-14 Andrx Labs, Llc Methods for treating diabetes via administration of controlled release metformin
US20060034922A1 (en) * 2000-11-03 2006-02-16 Andrx Labs, Llc Controlled release metformin compositions
AU2002230830A1 (en) 2000-11-03 2002-05-15 Andrx Labs, Llc Controlled release metformin compositions
US7491407B2 (en) * 2001-10-31 2009-02-17 North Carolina State University Fiber-based nano drug delivery systems (NDDS)
MXPA04006025A (es) * 2001-12-19 2005-03-31 Alza Corp Formulacion y forma de dosificacion para el suministro controlado de agentes terapeuticos.
US8871241B2 (en) 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
US20050208132A1 (en) * 2002-07-29 2005-09-22 Gayatri Sathyan Methods and dosage forms for reducing side effects of benzisozazole derivatives
US20050232995A1 (en) * 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
ES2529180T3 (es) 2002-09-20 2015-02-17 Andrx Labs Llc Formulación multietapa que contiene una biguanida y un derivado de tiazolidinodiona
US20050051922A1 (en) * 2002-09-20 2005-03-10 Avinash Nangia Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
DE60323138D1 (de) * 2002-12-12 2008-10-02 Nycomed Gmbh Kombinationsarzneimittel aus r,r-formoterol und ciclesonide
CA2538929A1 (en) * 2003-09-11 2005-03-24 Glykon Technologies Group, Llc Enteric delivery of (-)-hydroxycitric acid
WO2005025577A1 (en) * 2003-09-15 2005-03-24 Altana Pharma Ag Use of ciclesonide for the treatment of inflammatory bowel diseases
US8371292B2 (en) * 2003-09-16 2013-02-12 Nycomed Gmbh Use of ciclesonide for the treatment of respiratory diseases
US20050181050A1 (en) * 2004-01-28 2005-08-18 Collegium Pharmaceutical, Inc. Dosage forms using drug-loaded ion exchange resins
JP2007533706A (ja) * 2004-04-20 2007-11-22 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 喫煙患者における呼吸器疾患の治療のためのシクレソニドの使用
WO2005117591A2 (en) * 2004-05-28 2005-12-15 Andrx Labs Llc Novel pharmaceutical formulation containing a biguanide and an angiotensin antagonist
US20050287185A1 (en) * 2004-06-23 2005-12-29 David Wong Extended release oxybutynin formulation
US9011831B2 (en) * 2004-09-30 2015-04-21 Advanced Cardiovascular Systems, Inc. Methacrylate copolymers for medical devices
US7500679B2 (en) * 2004-10-08 2009-03-10 Wade James T Board for supporting front of snow vehicle
EP1846040A2 (en) * 2005-01-28 2007-10-24 Collegium Pharmaceutical, Inc. Non-ionic non-aqueous vehicles for topical and oral administration of carrier-complexed active agents
WO2007011972A2 (en) * 2005-07-19 2007-01-25 Inverseon, Inc. Improved pharmacokinetic profile of beta-adrenergic inverse agonists for the treatment of pulmonary airway diseases
US20070082084A1 (en) * 2005-10-07 2007-04-12 Catani Steven J Methods for weight management
US20070082114A1 (en) * 2005-10-07 2007-04-12 Catani Steven J Methods for reducing weight
US20070082115A1 (en) * 2005-10-07 2007-04-12 Aimutis William Ronald Jr Methods for inducing satiety, reducing food intake and reducing weight
US20070082026A1 (en) * 2005-10-07 2007-04-12 Aimutis William R Jr Compositions and methods for reducing food intake and controlling weight
US20070082029A1 (en) * 2005-10-07 2007-04-12 Aimutis William R Fiber satiety compositions
US20070082025A1 (en) * 2005-10-07 2007-04-12 Catani Steven J Methods for achieving and maintaining weight loss
US20070082030A1 (en) * 2005-10-07 2007-04-12 Aimutis William R Fiber satiety compositions
US20070082085A1 (en) * 2005-10-07 2007-04-12 Catani Steven J Compositions and methods for reducing food intake and controlling weight
US20070082108A1 (en) * 2005-10-07 2007-04-12 Aimutis William R Jr Methods for reducing calorie intake
US20070082028A1 (en) * 2005-10-07 2007-04-12 Aimutis William R Jr Compositions and methods for inducing satiety and reducing caloric intake
US20080085354A1 (en) * 2006-10-06 2008-04-10 Teresa Marie Paeschke Controlled hydration of hydrocolloids
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
US20090087484A1 (en) * 2007-09-28 2009-04-02 Alza Corporation Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
US8865688B2 (en) * 2008-10-03 2014-10-21 Dr. Falk Pharma Gmbh Compositions and methods for treatment of bowel diseases with granulated mesalamine
WO2011079232A1 (en) * 2009-12-23 2011-06-30 Psivida Us, Inc. Sustained release delivery devices
US20120238993A1 (en) * 2010-12-22 2012-09-20 Martin Nazzaro Two-piece injectable drug delivery device with heat-cured seal
EP3461477B1 (en) 2012-03-29 2021-06-30 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
CN110075130A (zh) 2013-03-14 2019-08-02 塞拉拜姆有限责任公司 益生生物和/或治疗剂的靶向胃肠道递送
CA2936740C (en) 2014-10-31 2017-10-10 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
EP3265064A4 (en) * 2015-03-04 2018-11-07 Microvention, Inc. Drug delivery device
US20180185378A1 (en) * 2017-01-05 2018-07-05 Cormedix Inc. Antimicrobial delivery system for the prevention and treatment of infections in the colon
US9707217B1 (en) 2017-02-03 2017-07-18 Osmotica Kereskedelmi Es Szolgaltato Kft Dose-dumping resistant controlled release dosage form
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
WO2022124914A1 (en) 2020-12-08 2022-06-16 Ruminant Biotech Corp Limited Improvements to devices and methods for delivery of substances to animals

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4036227A (en) * 1973-04-25 1977-07-19 Alza Corporation Osmotic releasing device having a plurality of release rate patterns
US4503030A (en) * 1983-06-06 1985-03-05 Alza Corporation Device for delivering drug to certain pH environments
US4717566A (en) * 1984-03-19 1988-01-05 Alza Corporation Dosage system and method of using same
US4627851A (en) * 1984-10-26 1986-12-09 Alza Corporation Colonic-therapeutic delivery system
US4904473A (en) * 1986-06-23 1990-02-27 International Minerals & Chemical Corp. Ruminant feed antacid containing potassium, sodium and chlorine
US4816262A (en) * 1986-08-28 1989-03-28 Universite De Montreal Controlled release tablet
US4810502A (en) * 1987-02-27 1989-03-07 Alza Corporation Pseudoephedrine brompheniramine therapy
US4904474A (en) * 1988-01-25 1990-02-27 Alza Corporation Delivery of drug to colon by oral disage form
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
GB8820353D0 (en) * 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet

Also Published As

Publication number Publication date
WO1991014426A1 (en) 1991-10-03
ZA912069B (en) 1991-12-24
ES2062779T3 (es) 1994-12-16
CA2038672A1 (en) 1991-09-24
IE910919A1 (en) 1991-09-25
FI924247A0 (fi) 1992-09-22
KR0169145B1 (ko) 1999-01-15
IE62393B1 (en) 1995-01-25
NZ237516A (en) 1993-04-28
MX173300B (es) 1994-02-14
NO923590L (no) 1992-11-23
ATE102029T1 (de) 1994-03-15
EP0521074A1 (en) 1993-01-07
PT97086B (pt) 1998-08-31
PT97086A (pt) 1991-10-31
EP0521074B1 (en) 1994-03-02
DE69101314D1 (de) 1994-04-07
US5178866A (en) 1993-01-12
CA2038672C (en) 2002-01-15
AU644645B2 (en) 1993-12-16
NO923590D0 (no) 1992-09-16
AU7581391A (en) 1991-10-21
KR930700074A (ko) 1993-03-13
JP2963766B2 (ja) 1999-10-18
DK0521074T3 (da) 1994-05-09
US5650170A (en) 1997-07-22
DE69101314T2 (de) 1994-06-09
JPH05506022A (ja) 1993-09-02

Similar Documents

Publication Publication Date Title
FI924247A (fi) En doseringsform foer frigoerande av medicin till tarmen
NO940376D0 (no) Doseringsanordning for avgivelse av medikament over et tidsrom med kort varighet
NO306377B1 (no) Doseform for avgivelse av et medikament
IT1270594B (it) Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
NO920740L (no) Doseringsform for oral administrering av hypoglykemisk glipizid
DE69728710D1 (de) Eine pharmazeutische Tablette charakterisiert durch hohen Volumenzuwachs bei Kontakt mit biologischen Flüssigkeiten
DK0871748T3 (da) Indgivelse af biologisk aktive polypeptider
IS3644A7 (is) Aðferð til að framleiða lyfjablöndu á formi smápilla til að meðhöndla þarmabólgur
DK0705204T3 (da) Poseemballage til flydende lægemidler
MY100780A (en) Azumolene dosage form.
NO930032L (no) Doseringsform for administrering av et medikament for aa frembringe circadian terapi
EA199800770A1 (ru) Лекарственный препарат для терапевтического лечения вирусного гепатита
GB1219026A (en) Tablet preparation
JPS6438027A (en) Remedy for cancer
IT1269412B (it) Apparecchio distributore di farmaci

Legal Events

Date Code Title Description
FD Application lapsed